| Announce Date | 10/09/2025 |
| EPS Normalized Actual | $0.98 (Beat by $0.12) |
| EPS GAAP Actual | $0.98 (Beat by $0.12) |
| Revenue Actual | $0.358194B |
| Revenue Surprise | Beat by $358.194M |
| Announce Date | 11/25/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.26 |
| EPS GAAP Estimate | $1.26 |
| Revenue Estimate | $1.019142B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2027 | 4.685 | 7.81 | 4.5 | 4.87 | 2 |
| Mar 2027 | 3.83 | 9.56 | 3.37216 | 4.28784 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 1.1 | -0.15 | 0.358194B | 4.4% | -8.61M |
| FQ2 2025 (May 2025) | -0.13 | -0.13 | 0.346622B | 4.36% | 346.62M |
| FQ1 2025 (Mar 2025) | 0 | 0 | 0.345694B | -4.67% | 345.69M |
| FQ4 2024 (Nov 2024) | 0.96 | 0.96 | 0.341344B | 0.48% | 341.34M |
| FQ3 2024 (Aug 2024) | 1.4 | 1.4 | 0.34244B | -3.28% | 342.44M |
| FQ2 2024 (Jun 2024) | 1.42 | 1.42 | 0.331516B | -9.11% | 331.52M |
| FQ1 2024 (Mar 2024) | 0.72 | 0.72 | 0.36184B | 100% | 361.84M |
| FQ4 2023 (Nov 2023) | 1.24 | 1.24 | 0.339714B | -8.28% | 339.71M |
FQ4 Announce Date
11/25/2025 (Pre-Market)
Consensus EPS Estimates
1.26
Consensus Revenue Estimates
1.019142B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Feb 2027) | 1.23 | -- | 1.17238 | 1.26925 | 1 |
| FQ4 2026 (Nov 2026) | 1.12 | -- | 1.06754 | 1.15574 | 1 |
| FQ3 2026 (Aug 2026) | 1.055 | -4.27 | 1.0475 | 1.06121 | 1 |
| FQ2 2026 (May 2026) | 0.805 | 116.15 | 0.79927 | 0.80974 | 1 |
| FQ1 2026 (Feb 2026) | 1.12 | -- | 1.12 | 1.12 | 1 |
| FQ4 2025 (Nov 2025) | 1.26 | 23.81 | 1.21846 | 1.29248 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Feb 2027) | 0.36B | -- | 0.35B | 0.37B | 2 |
| FQ4 2026 (Nov 2026) | 0.36B | -- | 0.35B | 0.37B | 1 |
| FQ3 2026 (Aug 2026) | 0.36B | 0.33 | 0.36B | 0.36B | 1 |
| FQ2 2026 (May 2026) | 0.35B | 0.52 | 0.35B | 0.35B | 1 |
| FQ1 2026 (Feb 2026) | 0.34B | -1.23 | 0.34B | 0.34B | 1 |
| FQ4 2025 (Nov 2025) | 1.02B | 66.51 | 0.99B | 1.04B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 1.25 | 1.1 | -0.15 | -13.64% |
| FQ2 2025 (May 2025) | -0.13 | -0.13 | 100% | |
| FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Nov 2024) | 0.96 | 0.96 | 100% | |
| FQ3 2024 (Aug 2024) | 1.4 | 1.4 | 100% | |
| FQ2 2024 (Jun 2024) | 1.42 | 1.42 | 100% | |
| FQ1 2024 (Mar 2024) | 0.72 | 0.72 | 100% | |
| FQ4 2023 (Nov 2023) | 1.24 | 1.24 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | $0.37B | $0.36B | $-8.61M | -2.4% |
| FQ2 2025 (May 2025) | $0B | $0.35B | $346.62M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.35B | $345.69M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.34B | $341.34M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $0.34B | $342.44M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.33B | $331.52M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.36B | $361.84M | 100% |
| FQ4 2023 (Nov 2023) | $0B | $0.34B | $339.71M | 100% |